RankingsPricing
  1. US-listed companies
  2. VERTEX PHARMACEUTICALS INC
  3. Financials
  4. Pretax margin (%)

VERTEX PHARMACEUTICALS INCVRTX

Market cap
$109.6B
P/E ratio
SummaryFinancials
Period EndPretax margin (%) YoY (%)
Dec 31, 20242.3-94.92%
Dec 31, 202344.4-6.36%
Dec 31, 202247.4+31.47%
Dec 31, 202136-28.23%
Dec 31, 202050.2+49.88%
Dec 31, 201933.5+70.13%
Dec 31, 201819.7-3224.19%
Dec 31, 2017-0.6-84.07%
Dec 31, 2016-4-92.68%
Dec 31, 2015-54-57.32%
Dec 31, 2014-126.6+57.21%
Dec 31, 2013-80.5+9833.53%
Dec 31, 2012-0.8-118.92%
Dec 31, 20114.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)